DiNAQOR Employee Directory

Biotechnology ResearchZurich, Switzerland2-10 Employees

DiNAQOR operates as a biotechnology platform focused on genetic medicines, concentrating on early-stage drug development and manufacturing to advance gene therapies toward the clinic. Its platform is patent-protected and combines engineered heart tissue technology with a loco-regional perfusion approach and a fully integrated manufacturing solution to address common obstacles in advancing gene therapies. The company is headquartered in Schlieren, in the Zurich region of Switzerland, with additional presence in Laguna Hills, California, and Hamburg, Germany, and maintains a small, specialized team.

Its customers are developers of genetic medicines aiming to bring cardiac-related therapies to clinical use, relying on DiNAQOR to accelerate development timelines while managing cost and risk via its DiNAMIQS biomanufacturing subsidiary, launched in 2022. A recent development in December 2025 involved leadership appointments intended to strengthen strategy and scientific leadership across the group.

Sign up for free to view info

Company overview Email format